Cargando…
YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy
BACKGROUND: Recurrence of Hepatitis B Virus infection in patients undergoing liver transplanted (LT) is a serious and often fatal problem. Lamivudine (LAM) and Hepatitis B Immunoglobulin (HBIG) are widely used to manage hepatitis B recurrence after liver transplantation. However, the outcomes in pat...
Autores principales: | Rahimi, Rahim, Hosseini, Seyed Younes, Fattahi, Mohammad Reza, Sepehrimanesh, Masood, Safarpour, Alireza, Malekhosseini, Seyed Ali, Nejabat, Maryam, Khodadad, Mahboobeh, Ardebili, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539793/ https://www.ncbi.nlm.nih.gov/pubmed/26300928 http://dx.doi.org/10.5812/hepatmon.27120v2 |
Ejemplares similares
-
YMDD motif mutation after lamivudine therapy
por: Jazayeri, Seyed Mohammad, et al.
Publicado: (2011) -
Evaluation of hepatitis C virus intrafamilial transmission among families with one index case, a pilot study from Fars province, Iran
por: Lankarani, Kamran B., et al.
Publicado: (2016) -
Analysis of Naturally Occurring Resistant Mutations to Hepatitis C Virus NS3 Protease Inhibitors: A Preliminary Study in South of Iran
por: Afrasiabi, Mozhgan, et al.
Publicado: (2015) -
Detection of YMDD Motif Mutants by Oligonucleotide Chips in Lamivudine-Untreated Patients with Chronic Hepatitis B Virus Infection
por: Heo, Jeong, et al.
Publicado: (2004) -
Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection
por: Ghandehari, Freshte, et al.
Publicado: (2011)